Professor Luregn Schlapbach is Head of the 41-bed multidisciplinary Pediatric and Neonatal Intensive Care Unit at the University Children`s Hospital Zurich, Switzerland. He has published over 130 papers in the field including leading journals such as NEJM, JAMA, and Lancet, and has received over US$10M grants for his research.
Prof. Schlapbach grew up in Zurich, Switzerland, and was trained in pediatrics, neonatology, and pediatric intensive care in Switzerland and Australia. After having worked since 2013 as senior Staff Specialist in pediatric intensive care, including Australias largest ICU at Queensland Children`s Hospital in Brisbane, Australia) he relocated to Zurich in August 2020 where he is now leading the Department of Pediatric and Neonatal Intensive Care.
Prof. Schlapbach is leading the Pediatric and Neonatal Intensive Care research group at the Children`s Research Center, University of Zurich, and maintains an active research program on Sepsis, Infection, and Inflammation in Critically Ill Children at the Child Health Research Centre, University of Queensland.
Prof. Schlapbach`s research has focused on sepsis and life-threatening infections in critically ill neonates and children, including aspects such as epidemiology, sepsis markers, outcomes and genomics in this highly vulnerable patient group. He is interested in improving our understanding of why some children become critically unwell because of infections, and in developing better approaches to allow early recognition and targeted treatment of sepsis, severe infection and inflammation in children. He has been leading observational, genomic, and interventional studies in the field, is involved in international consortia on life-threatening childhood infections, and serves in the steering board of several large pediatric trials. He is Past Chair of the Australian and New Zealand Intensive Care Society Paediatric Study Group.
Prof. Schlapbach is an internationally recognized expert in sepsis and other life-threatening infectious and inflammatory conditions, as evidenced by his work as group head on the Pediatric Surviving Sepsis Campaign, and Co-Chairmanship of the international Paediatric Sepsis Definition Taskforce. In recognition for his contribution to quality improvement initiatives for critically ill children, Prof. Schlapbach recently has been elected for the Global Sepsis Alliance Executive.